NDI Guidance Protects Public Health And Allows Innovation – FDA's Fabricant
This article was originally published in The Tan Sheet
Present and former top FDA officials with oversight of dietary supplements defend the draft guidance on new dietary ingredient notifications, saying the document serves important public health priorities and will not be onerous to industry.
You may also be interested in...
FDA’s new dietary ingredient notification draft guidance draws questions even from firms that expect compliance will not require drastic changes in their processes.
The volume of noncompliant supplement ingredients on the market likely will prompt an uptick in enforcement after FDA releases its NDI notification guidance, which will draw attention to the problem, dietary supplement program chief Daniel Fabricant says.
FDA will hold a public comment meeting Nov. 15 on the Dietary Supplement Health & Education Act's premarket notification program for new dietary ingredients (NDIs)